Disruptions to funding and new policies aimed at aligning foreign aid programs with the Trump administration’s agenda have ...

A study reveals economic inequality is a key predictor of pandemic response effectiveness, urging nations to prioritize ...

A South African clinical trial has found a new HIV treatment regimen causes significantly less weight gain than the standard dolutegravir treatment.

South Africa accounts for over half of all lenacapavir (LEN) users in Africa, with health department data revealing 31,297 of ...

Around 77,000 fewer children worldwide received HIV treatment supported by the U.S. since October 2025 than in the previous ...

Among healthcare providers, 89% (n=16/18) reported a positive overall opinion of administering CAB LA for PrEP in their practice. Prescribers cited benefits of regular injection visits, including ...

Dovato is indicated for the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults and adolescents above 12 years of age weighing at least 40 kg in the EU, and weighing at least ...

ViiV Healthcare’s Dovato has been approved for use in the US and EU since 2019, but its sales remain overshadowed by Gilead’s Biktarvy.

Economic inequality is the clearest way to predict how countries will fare during a pandemic, a high-profile panel said ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, announced today that it will make three ...

Researchers at the UC Davis School of Medicine have identified a naturally occurring metabolite that repairs gut damage ...

A new research study examining the scale of disruptions to HIV programmes caused by funding cuts from the United States’ ...